financetom
Business
financetom
/
Business
/
Duolingo forecasts annual revenue above estimates on strong adoption of AI features
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Duolingo forecasts annual revenue above estimates on strong adoption of AI features
Feb 27, 2025 1:18 PM

Feb 27 (Reuters) - Language learning app Duolingo ( DUOL ) forecast annual revenue above

Wall Street expectations on Thursday, anticipating a stronger adoption of its subscription tier

featuring artificial intelligence capabilities.

The company operates a "freemium" model, providing a basic set of features for all users at

no cost with additional capabilities available through monthly or annual paid subscriptions.

Duolingo ( DUOL ) runs two subscription tiers - Super for avid users, and Max, which includes a

generative AI-driven feature that simulates natural conversations through video calls.

Over the past few months, Duolingo ( DUOL ) has expanded the feature to a slew of languages to rake

in more subscribers and grow revenue, but the video call feature on its Max subscription added

to costs.

It expects revenue for 2025 to be in the range of $962.5 million to $978.5 million, compared

to analysts' estimate of $965.9 million, according to data compiled by LSEG.

Duolingo ( DUOL ) forecast revenue for the first quarter ranging from $220.5 million to $223.5

million. Analysts, on average, were expecting $221.1 million.

"There's a marginal cost to Max, and that marginal cost is we call generative AI models to

power what is the most important part of Max, which is the video call, and that did have about a

100-basis-point impact to gross margin," Chief Financial Officer Matt Skaruppa told Reuters.

"The first priority is innovating as quickly as possible, experimenting as quickly as

possible to drive more engagement, and then the costs will come down over time."

The firm also forecast adjusted core profit between $259.9 million and $274 million this

year, below estimates of $272.1 million, largely due to costs related to its AI video call

features.

The company said chatter around the TikTok ban in January and a marketing campaign in which

the app's mascot, Duo, faked his death and returned led to a jump in users in February.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved